NCT00859469View on ClinicalTrials.gov

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2013

Conditions
Mesothelioma
Interventions
DRUG

Oxaliplatin

Oxaliplatin 100 mg/m2 IV infusion for 2 hours

DRUG

Gemcitabine

Gemcitabine 1000mg/m2 IV infusion for 90 minutes

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT00859469 - Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma | Biotech Hunter | Biotech Hunter